Pasireotide for the Treatment of Refractory Hypoglycemia from Malignant Insulinoma

Imprimir

Pasireotide for the Treatment of Refractory Hypoglycemia from Malignant Insulinoma

Clinical Endocrinology 2017 October

Abstract